Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)
NCT03585855 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2019-07-25
Summary
Transplant rejection is one of the biggest limitations in renal transplant procedures, where the kidney can undergo an acute, late acute, or chronic transplant rejection. With the advancement in transplantation protocols, acute survival of renal transplants has improved, but long-term survival is still unsatisfactory, as most of the renal transplants develop chronic graft rejection. Unfortunately, there is little the investigators know when it comes to improving long-term survival of renal transplants. Mesenchymal stem cells (MSC) have been shown to have immunosuppressive and repairing properties. The purpose of this study is to find out whether MSC in combination with standard therapy of antibody mediated rejection (ABMR) are more effective in preventing organ deterioration and maintaining kidney function.
Conditions
- Interventional
Interventions
- OTHER
-
MSC transplantation
MSC transplantation: patients with ABMR treated with MSC transplantation
Sponsors & Collaborators
-
Slovenian Research Agency
collaborator OTHER -
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Željka Večerić-Haler, MDPhD · assist.prof.Željka Večerić-Haler, MDPhD
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2019-07-23
- Completion
- 2019-07-23
Countries
- Slovenia
Study Locations
More Related Trials
-
Cell-based Assays for Antibody-mediated Transplant Rejection
NCT03916822 ·Status: UNKNOWN
-
Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection
NCT04367610 ·Status: COMPLETED
-
A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties
NCT00980317 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Acute Rejection in Renal Transplant
NCT00205257 ·Status: COMPLETED
-
Diagnosis of Acute Rejection in Renal Transplant Patients by Urine Mass Spectrometry
NCT01315067 ·Status: COMPLETED
-
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
NCT05907096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Impact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant Recipients
NCT05431712 ·Status: COMPLETED
-
Pre-formed Alloreactivity in Renal Transplant Recipients
NCT02633826 ·Status: COMPLETED
-
Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response
NCT03430414 ·Status: UNKNOWN
-
A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members
NCT00994188 ·Status: UNKNOWN ·Phase: NA
-
MiRNA in Kidney Transplantation: Association With Kidney Graft Function and Disease Process
NCT04413916 ·Status: COMPLETED
-
Urine Biomarker for Kidney Transplant Rejection
NCT05072951 ·Status: NOT_YET_RECRUITING
-
Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function
NCT02568696 ·Status: UNKNOWN
-
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
NCT00275717 ·Status: COMPLETED
-
Impact of Microvascular Inflammation on Kidney Allograft Outcome
NCT06496269 ·Status: COMPLETED
-
Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation
NCT03098238 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies
NCT05306795 ·Status: UNKNOWN
-
Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation
NCT06809075 ·Status: RECRUITING ·Phase: NA
-
Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
NCT01756508 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Long-term Deterioration of Kidney Transplants.
NCT00217126 ·Status: COMPLETED
-
A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death
NCT02490020 ·Status: UNKNOWN ·Phase: PHASE1
-
To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation
NCT07145944 ·Status: NOT_YET_RECRUITING
-
Induction With SVF Derived MSC in Living-related Kidney Transplantation
NCT02492308 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
MRI in Renal Transplantation
NCT03705091 ·Status: UNKNOWN
-
Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
NCT06794970 ·Status: RECRUITING